284 related articles for article (PubMed ID: 33159966)
1. Upgrade rate of intraductal papilloma diagnosed on core needle biopsy in a single institution.
Lin LH; Ozerdem U; Cotzia P; Lee J; Chun J; Schnabel F; Darvishian F
Hum Pathol; 2021 Apr; 110():43-49. PubMed ID: 33159966
[TBL] [Abstract][Full Text] [Related]
2. Upgrade rates of intraductal papilloma with and without atypia diagnosed on core needle biopsy and clinicopathologic predictors.
Corbin H; Bomeisl P; Amin AL; Marshall HN; Gilmore H; Harbhajanka A
Hum Pathol; 2022 Oct; 128():90-100. PubMed ID: 35863513
[TBL] [Abstract][Full Text] [Related]
3. Surgical follow-up and clinical presentation of 142 breast papillary lesions diagnosed by ultrasound-guided core-needle biopsy.
Rizzo M; Lund MJ; Oprea G; Schniederjan M; Wood WC; Mosunjac M
Ann Surg Oncol; 2008 Apr; 15(4):1040-7. PubMed ID: 18204989
[TBL] [Abstract][Full Text] [Related]
4. Breast intraductal papillomas without atypia in radiologic-pathologic concordant core-needle biopsies: Rate of upgrade to carcinoma at excision.
Pareja F; Corben AD; Brennan SB; Murray MP; Bowser ZL; Jakate K; Sebastiano C; Morrow M; Morris EA; Brogi E
Cancer; 2016 Sep; 122(18):2819-27. PubMed ID: 27315013
[TBL] [Abstract][Full Text] [Related]
5. Upgrade rate of intraductal papilloma without atypia on breast core needle biopsy: A clinical, radiological and pathological correlation study.
Genco IS; Tugertimur B; Manolas PA; Hasanovic A; Hajiyeva S
Am J Surg; 2020 Sep; 220(3):677-681. PubMed ID: 32007236
[TBL] [Abstract][Full Text] [Related]
6. Does previous history of cancer or atypia predict histologic upgrade for pure intraductal papillomas diagnosed via core biopsy? A study of 490 cases at a single institution.
Alberty-Oller JJ; Reyes S; Moshier E; Ru M; Weltz S; Santos A; Pisapati K; Port E; Jaffer S
Cancer Rep (Hoboken); 2022 Mar; 5(3):e1481. PubMed ID: 34729946
[TBL] [Abstract][Full Text] [Related]
7. Atypical ductal hyperplasia bordering on DCIS on core biopsy is associated with higher risk of upgrade than conventional atypical ductal hyperplasia.
Pawloski KR; Christian N; Knezevic A; Wen HY; Van Zee KJ; Morrow M; Tadros AB
Breast Cancer Res Treat; 2020 Dec; 184(3):873-880. PubMed ID: 32857242
[TBL] [Abstract][Full Text] [Related]
8. Audit on Intraductal Papilloma of the Breast: Upgrade Rate, Management Pitfalls, and Updated Guidelines in a Tertiary Health Care Center.
Esmayil H; Abayazeed S; Hajaj M
Cureus; 2021 Oct; 13(10):e18763. PubMed ID: 34796058
[TBL] [Abstract][Full Text] [Related]
9. Intraductal papillomas on core biopsy can be upgraded to malignancy on subsequent excisional biopsy regardless of the presence of atypical features.
Shiino S; Tsuda H; Yoshida M; Jimbo K; Asaga S; Hojo T; Kinoshita T
Pathol Int; 2015 Jun; 65(6):293-300. PubMed ID: 25801805
[TBL] [Abstract][Full Text] [Related]
10. Papillary lesions of the breast: To excise or observe?
Khan S; Diaz A; Archer KJ; Lehman RR; Mullins T; Cardenosa G; Bear HD
Breast J; 2018 May; 24(3):350-355. PubMed ID: 28845569
[TBL] [Abstract][Full Text] [Related]
11. The Management Strategy of Benign Solitary Intraductal Papilloma on Breast Core Biopsy.
Ko D; Kang E; Park SY; Kim SM; Jang M; Yun B; Chae S; Jang Y; Kim HJ; Kim SW; Kim EK
Clin Breast Cancer; 2017 Aug; 17(5):367-372. PubMed ID: 28438672
[TBL] [Abstract][Full Text] [Related]
12. Management of papillary breast lesions diagnosed on core-needle biopsy: clinical pathologic and radiologic analysis of 276 cases with surgical follow-up.
Rizzo M; Linebarger J; Lowe MC; Pan L; Gabram SG; Vasquez L; Cohen MA; Mosunjac M
J Am Coll Surg; 2012 Mar; 214(3):280-7. PubMed ID: 22244207
[TBL] [Abstract][Full Text] [Related]
13. Breast Cancer Risk Associated With Benign Intraductal Papillomas Initially Diagnosed on Core Needle Biopsy.
Nasehi L; Sturgis CD; Sharma N; Turk P; Calhoun BC
Clin Breast Cancer; 2018 Dec; 18(6):468-473. PubMed ID: 30017794
[TBL] [Abstract][Full Text] [Related]
14. Atypical ductal hyperplasia on core needle biopsy: Development of a predictive model stratifying carcinoma upgrade risk on excision.
Salagean ED; Slodkowska E; Nofech-Mozes S; Hanna W; Parra-Herran C; Lu FI
Breast J; 2019 Jan; 25(1):56-61. PubMed ID: 30461131
[TBL] [Abstract][Full Text] [Related]
15. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
[TBL] [Abstract][Full Text] [Related]
16. Are we overtreating intraductal papillomas?
Kiran S; Jeong YJ; Nelson ME; Ring A; Johnson MB; Sheth PA; Ma Y; Sener SF; Lang JE
J Surg Res; 2018 Nov; 231():387-394. PubMed ID: 30278958
[TBL] [Abstract][Full Text] [Related]
17. Papilloma diagnosed on core biopsies has a low upgrade rate.
Li X; Aho M; Newell MS; Clifford K; Patel JG; Jou S; Cohen MA
Clin Imaging; 2020 Mar; 60(1):67-74. PubMed ID: 31864203
[TBL] [Abstract][Full Text] [Related]
18. Benign Breast Intraductal Papillomas Without Atypia at Core Needle Biopsies: Is Surgical Excision Necessary?
Moseley T; Desai B; Whitman GJ; Robinson EK; Saunders T; Gonzalez A; He H
Ann Surg Oncol; 2021 Mar; 28(3):1347-1355. PubMed ID: 32860176
[TBL] [Abstract][Full Text] [Related]
19. High-Risk Lesions Detected by MRI-Guided Core Biopsy: Upgrade Rates at Surgical Excision and Implications for Management.
Michaels AY; Ginter PS; Dodelzon K; Naunheim MR; Abbey GN
AJR Am J Roentgenol; 2021 Mar; 216(3):622-632. PubMed ID: 33439046
[No Abstract] [Full Text] [Related]
20. Multidisciplinary Review of Intraductal Papilloma of the Breast can Identify Patients who may Omit Surgical Excision.
Abbassi-Rahbar S; Sack S; Larson KE; Wagner JL; Kilgore LJ; Balanoff CR; Winblad OD; Amin AL
Ann Surg Oncol; 2021 Oct; 28(10):5768-5774. PubMed ID: 34338925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
